GLP-1 RAs don't suppress insulin secretion or alter ketone metabolism in the same way, making their safety profile meaningfully different
Hunter Guevara LR, Beam WBB, Pasternak JJ (2024) To the Brain and Beyond: Neurological Implications of Glucagon-Like Peptide-1 Receptor Agonists
Are not ready for a procedure
The same study also reported fewer cases of respiratory failure, pneumonia, substance use disorders, and seizures
4 Others: GIPR/GLP-1R dual agonists and GIPR/GLP-1R/GCGR triagonists Intestinal endocrine K cells produce gastric inhibitory polypeptide (GIP)
Storage and handling Store and handle according to the product label, supplied documentation, and laboratory standard operating procedures